Experimental study on anti-tumor effect of splenocytes induced by anti-CD3 McAb, PHA and IL-2

J Tongji Med Univ. 1994;14(1):12-5. doi: 10.1007/BF02888050.

Abstract

The proliferation of splenocytes from healthy adults was induced by anti-CD3 McAb, PHA and IL-2. The proliferative capability and anti-tumor activity as well as phenotypes of the splenocytes cultured in different medium systems were studied. The results showed that anti-CD3 McAb and PHA not only enhanced the proliferation of splenocytes induced by IL-2, but also produced synergism if used simultaneously. The expressions of CD4 and Tac of cellular surface markers were increased after splenocytes were induced by anti-CD3 McAb and PHA. The results of anti-tumor activity of LAK cells suggested that PHA had the capability to promote anti-tumor activity of LAK cells by both direct and indirect pathways, but anti-CD3 McAb indirectly promoted anti-tumor activity of LAK cells by enhancing splenocyte proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Burkitt Lymphoma / pathology
  • CD3 Complex / immunology*
  • Cytotoxicity, Immunologic*
  • Humans
  • Interleukin-2 / pharmacology
  • Killer Cells, Lymphokine-Activated / immunology
  • Phytohemagglutinins / pharmacology
  • Recombinant Proteins / pharmacology
  • Spleen / cytology
  • Spleen / immunology*
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • CD3 Complex
  • Interleukin-2
  • Phytohemagglutinins
  • Recombinant Proteins